National Research Co. (NASDAQ:NRC) Position Increased by Inspire Investing LLC

Inspire Investing LLC increased its holdings in National Research Co. (NASDAQ:NRC) by 26.1% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 22,952 shares of the company’s stock after buying an additional 4,746 shares during the period. Inspire Investing LLC owned about 0.10% of National Research worth $405,000 as of its most recent filing with the SEC.

A number of other institutional investors have also modified their holdings of NRC. American Century Companies Inc. increased its position in National Research by 13.3% in the second quarter. American Century Companies Inc. now owns 31,231 shares of the company’s stock worth $717,000 after buying an additional 3,657 shares during the period. Benjamin F. Edwards & Company Inc. increased its holdings in shares of National Research by 145.6% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 2,783 shares of the company’s stock worth $64,000 after acquiring an additional 1,650 shares during the period. Marshall Wace LLP bought a new stake in National Research in the 2nd quarter valued at about $1,644,000. Cubist Systematic Strategies LLC lifted its position in National Research by 40.3% in the 2nd quarter. Cubist Systematic Strategies LLC now owns 22,287 shares of the company’s stock valued at $511,000 after purchasing an additional 6,398 shares during the last quarter. Finally, Squarepoint Ops LLC bought a new position in National Research in the 2nd quarter worth about $845,000. Institutional investors own 47.26% of the company’s stock.

National Research Price Performance

Shares of NASDAQ:NRC opened at $17.96 on Friday. The company has a current ratio of 0.47, a quick ratio of 0.47 and a debt-to-equity ratio of 1.30. The firm’s 50 day moving average is $18.15 and its two-hundred day moving average is $20.26. The firm has a market capitalization of $421.63 million, a P/E ratio of 15.89 and a beta of 0.53. National Research Co. has a 52 week low of $16.50 and a 52 week high of $42.00.

National Research (NASDAQ:NRC) last announced its earnings results on Friday, October 25th. The company reported $0.24 earnings per share for the quarter. National Research had a return on equity of 67.40% and a net margin of 18.78%. The firm had revenue of $35.82 million for the quarter.

National Research Profile

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.